| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) |
|
12230.75 | -121.60 | -0.98% |
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Vivimed Labs Limited (NSE: VIVIMEDLAB)
VIVIMEDLAB Technical Analysis
2
| As on 20th Jan 2020 VIVIMEDLAB Share Price closed @ 13.35 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 17.70 & Buy for SHORT-TERM with Stoploss of 12.81 we also expect STOCK to react on Following IMPORTANT LEVELS. |
VIVIMEDLAB Share Price
| Open | 13.05 | Change | Price | % |
| High | 14.50 | 1 Day | 1.10 | 8.98 |
| Low | 13.05 | 1 Week | 1.00 | 8.10 |
| Close | 13.35 | 1 Month | 0.35 | 2.69 |
| Volume | 1594501 | 1 Year | -19.95 | -59.91 |
| 52 Week High 33.70 | 52 Week Low 10.15 | ||||
NSE INDIA Most Active Stocks
| IDEA | 4.85 | 7.78% |
| YESBANK | 38.65 | -1.53% |
| NHPC | 27.05 | 11.55% |
| IOC | 117.50 | -4.20% |
| BHARTIARTL | 508.70 | 1.73% |
| FEDERALBNK | 93.75 | 2.35% |
| SBIN | 314.00 | -1.26% |
| TATAMOTORS | 195.00 | -1.17% |
| DISHTV | 12.75 | -2.67% |
| POWERGRID | 204.65 | 3.67% |
NSE INDIA Top Gainers Stocks
NSE INDIA Top Losers Stocks
| VISESHINFO | 0.05 | -50.00% |
| BLUECHIP | 0.10 | -33.33% |
| SPYL | 0.30 | -14.29% |
| GTLINFRA | 0.35 | -12.50% |
| GNA | 281.25 | -11.43% |
| GNA | 281.25 | -11.43% |
| GAYAHWS | 0.40 | -11.11% |
| AGARIND | 92.25 | -10.00% |
| TIJARIA | 7.80 | -9.83% |
| ROHITFERRO | 0.50 | -9.09% |
| VIVIMEDLAB Daily Charts |
VIVIMEDLAB Intraday Charts |
Whats New @ Bazaartrend |
VIVIMEDLAB Free Analysis |
|
|
VIVIMEDLAB Important Levels Intraday
| RESISTANCE | 16.14 |
| RESISTANCE | 15.25 |
| RESISTANCE | 14.69 |
| RESISTANCE | 14.14 |
| SUPPORT | 12.56 |
| SUPPORT | 12.01 |
| SUPPORT | 11.45 |
| SUPPORT | 10.56 |
VIVIMEDLAB Target for Month January
| 4th UP TARGET | 19.58 |
| 3rd UP TARGET | 17.29 |
| 2nd UP TARGET | 15.88 |
| 1st UP TARGET | 14.47 |
| 1st DOWN TARGET | 10.43 |
| 2nd DOWN TARGET | 9.02 |
| 3rd DOWN TARGET | 7.61 |
| 4th DOWN TARGET | 5.32 |
VIVIMEDLAB Weekly Target
| 4th UP TARGET | 13.79 |
| 3rd UP TARGET | 13.30 |
| 2nd UP TARGET | 12.99 |
| 1st UP TARGET | 12.69 |
| 1st DOWN TARGET | 11.81 |
| 2nd DOWN TARGET | 11.51 |
| 3rd DOWN TARGET | 11.20 |
| 4th DOWN TARGET | 10.71 |
VIVIMEDLAB Target for Year 2020
| 4th UP TARGET | 66.5 |
| 3rd UP TARGET | 49.17 |
| 2nd UP TARGET | 38.45 |
| 1st UP TARGET | 27.74 |
| 1st DOWN TARGET | -2.84 |
| 2nd DOWN TARGET | -13.55 |
| 3rd DOWN TARGET | -24.27 |
| 4th DOWN TARGET | -41.6 |
Vivimed Labs Limited ( NSE INDIA Symbol : VIVIMEDLAB )
Sector : Services And Other Stocks in Same Sector
Sector : Services And Other Stocks in Same Sector
VIVIMEDLAB Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Below EMA 100 (Mid Term) | Bearish | |
| 200 Day EMA | Close is Below EMA 200 (Long Term) | Bearish | |
| MACD (12 26 9) | N/A | N/A | |
| RSI (14) | RSI is 44.82 | Sideways | |
| MFI (14) | MFI is 53.44 | Sideways | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is Below -80 | Over Sold | |
| ADX (14) | ADX is 11.09 | Range Bound | |
| PSAR | Stoploss For Short Sell | 14.25 | |
| 10 Day Avg Volume | Traded 3.91 % More then 10 Day Average Volume | ||
VIVIMEDLAB Other Details
| Segment | EQ | |
| Market Capital | 0.00 | |
| Sector | Services | |
| Industry | Business Services | |
| Offical website | http://www.vivimedlabs.com | |
VIVIMEDLAB Address
 |
Veeranag Towers 2nd Floor Hyderabad, 500007 India Phone: 91 40 2717 6005 Fax: 91 40 2717 2242 |
|
VIVIMEDLAB Latest News
| Should You Be Concerned About Cordlife Group Limited's (SGX:P8A) Investors? - Simply Wall St - 13th Jul 18 |
| Does Vivimed Labs Limited's (NSE:VIVIMEDLAB) PE Ratio Signal A Buying Opportunity? - Simply Wall St - 28th May 18 |
| Does Tecnotree Oyj (HEL:TEM1V) Fall With The Market? - Simply Wall St - 07th May 18 |
| Buy Vivimed Labs Ltd; target of Rs 134: KR Choksey Moneycontrol.com - 21st Mar 18 |
| Buy Vivimed Labs Ltd; target of Rs 134: KR Choksey Moneycontrol.com - 21st Mar 18 |
| Vivimed Labs Ltd. NDTV Profit - 19th Mar 18 |
| Vivimed Labs Ltd to consider preferential issue on Mar 22, 2018 Equity Bulls - 19th Mar 18 |
| VIVIMED LABS LTD. (VIVIMEDLAB.BO) Shares Placed Under the Microscope Kaplan Herald - 06th Mar 18 |
| Should You Be Tempted To Buy Vivimed Labs Limited (NSE:VIVIMEDLAB) At Its ... Simply Wall St - 22nd Feb 18 |
| Can Ruchira Papers Limited (NSE:RUCHIRA) Continue To Outperform Its Industry? - Simply Wall St - 22nd Feb 18 |
VIVIMEDLAB Business Profile
Vivimed Labs Limited, together with its subsidiaries, manufactures and sells specialty chemicals and pharmaceutical products in India and internationally. It operates through two segments, Speciality Chemicals and Pharmaceuticals. The company manufactures active ingredients, which are used in home and personal care segments, such as hair, skin, oral care, and anti-microbial preservatives, as well as used in industrial care segments comprising photo chromic dyes and imaging chemicals. Its products include antibacterials for toothpaste and mouthwash, and neutraceuticals for dental enamel protection in the oralcare market; UV filters for sun care products; skin care ingredients, such as active anti-wrinkle, anti-ageing compounds, anti-oxidants, skin-lightening actives, and emollients for use in skin care products; hair dye intermediates, anti-dandruff actives, and thickeners and conditioners for use in hair care products. The company also provides photochromic dyes for applications in plastics, films, coatings, and inks; anti-microbial actives for use in a range of applications from plastics additives to anti-bacterial hand washes; preservatives for various formulations; and photographic chemicals for use in the medical and industrial X-ray imaging, consumer photography, and litho-plate production for the graphic arts industry. In addition, it offers nutraceuticals for women and children, enzyme preparations, beta-lactams, heamatinics, anti-oxidants, cough expectorants, and multi-vitamins, as well as provides drugs for curing oncology space, arthritis, syndrome X, macular degeneration, psoriasis, and stress. Further, the company manufactures and markets active pharmaceutical ingredients and finished dosage formulations, which covers therapeutic segments, as well as provides contract manufacturing services and manufactures branded formulations. Vivimed Labs Limited was founded in 1988 and is headquartered in Hyderabad, India.
© 2005-2019 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
